| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DIA.MI - DiaSorin SpA | BUY | 96 @ EUR 98.12 | EUR 9,420 | The ETF bought 96 new shares of DIA.MI (DiaSorin SpA). The shares were bought for an average price of 98.12 compared to the previous average buy price of 95.9699. This is 2.2% higher than average price of previous purchases of DIA.MI. |
| BANB.SW - | HOLD | 0 @ CHF 51.563 | CHF 0 | The current share valuation price of BANB.SW based on adjusted close was CHF 51.563. The average price that BANB.SW shares were previous bought at was CHF 54.3418. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in BANB.SW has fallen by CHF 8,034 (USD $9,788) compared to the previous valuation of |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.5 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.5. The average price that REC.MI shares were previous bought at was EUR 53.243. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 6,172 (USD $6,970) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.3 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.3. The average price that BIM.PA shares were previous bought at was EUR 112.653. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 9,651 (USD $10,899) compared to the previous valuation of BioMerieux |
| GALD.SW - | HOLD | 0 @ CHF 84.4119 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 84.4119. The average price that GALD.SW shares were previous bought at was CHF 106.599. The current market price is -20.8% lower than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 55,370 (USD $67,461) compared to the previous valuation of |
| SFZN.SW - | HOLD | 0 @ CHF 954.55 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 954.55. The average price that SFZN.SW shares were previous bought at was CHF 1014.44. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in SFZN.SW has fallen by CHF 1,742 (USD $2,122) compared to the previous valuation of |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 49.34 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 49.34. The average price that ORNBV.HE shares were previous bought at was EUR 51.589. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 25,104 (USD $28,349) compared to the previous valuation of Orion Oyj |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 94.8 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 94.8. The average price that IPN.PA shares were previous bought at was EUR 108.128. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 63,231 (USD $71,405) compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 22.0217 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 22.0217. The average price that HIK.L shares were previous bought at was GBP 24.2327. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 17,836 (USD $23,599) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.214 | EUR 0 | |
| DEMANT.CO - | HOLD | 0 @ DKK 29.9418 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.9418. The average price that DEMANT.CO shares were previous bought at was DKK 32.1673. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 18,764 (USD $2,838) compared to the previous valuation of |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 16.36 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 16.36. The average price that AMP.MI shares were previous bought at was EUR 20.7139. The current market price is -21.0% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 20,248 (USD $22,865) compared to the previous valuation of Amplifon SpA |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 111.6 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 111.6. The average price that TUB.BR shares were previous bought at was EUR 133.283. The current market price is -16.3% lower than average price they were purchased at. The value of the holding in TUB.BR has fallen by EUR 18,467 (USD $20,854) compared to the previous valuation of Financiere de Tubize SA |
| TECN.SW - | HOLD | 0 @ CHF 155.034 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 155.034. The average price that TECN.SW shares were previous bought at was CHF 192.309. The current market price is -19.4% lower than average price they were purchased at. The value of the holding in TECN.SW has fallen by CHF 17,188 (USD $20,941) compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 191.35 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 191.35. The average price that DIM.PA shares were previous bought at was EUR 186.847. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 203,098 (USD $229,352) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| GXI.DE - Gerresheimer AG | HOLD | 0 @ EUR 50.8 | EUR 0 | The current share valuation price of GXI.DE based on adjusted close was EUR 50.8. The average price that GXI.DE shares were previous bought at was EUR 68.7246. The current market price is -26.1% lower than average price they were purchased at. The value of the holding in GXI.DE has fallen by EUR 3,795 (USD $4,286) compared to the previous valuation of Gerresheimer AG |
| BAVA.CO - | HOLD | 0 @ DKK 20.3071 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 20.3071. The average price that BAVA.CO shares were previous bought at was DKK 20.6449. The current market price is -1.6% lower than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 2,535 (USD $383) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| AFX.DE - Carl Zeiss Meditec AG | HOLD | 0 @ EUR 57.7 | EUR 0 | The current share valuation price of AFX.DE based on adjusted close was EUR 57.7. The average price that AFX.DE shares were previous bought at was EUR 51.2. The current market price is 12.7% higher than average price they were purchased at. The value of the holding in AFX.DE has increased by EUR 1,458 (USD $1,646) compared to the previous valuation of Carl Zeiss Meditec AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 56.4086 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 56.4086. The average price that NOVO-B.CO shares were previous bought at was DKK 67.492. The current market price is -16.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 772,200 (USD $116,796) compared to the previous valuation of Novo Nordisk A/S |
| NSIS-B.CO - | HOLD | 0 @ DKK 54.8888 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 54.8888. The average price that NSIS-B.CO shares were previous bought at was DKK 53.0372. The current market price is 3.5% higher than average price they were purchased at. The value of the holding in NSIS-B.CO has fallen by DKK 4,586 (USD $694) compared to the previous valuation of |
| COLO-B.CO - | HOLD | 0 @ DKK 94.0568 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 94.0568. The average price that COLO-B.CO shares were previous bought at was DKK 98.9579. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 427 (USD $65) compared to the previous valuation of |
| SECT-B.ST - | HOLD | 0 @ SEK 24.6551 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 24.6551. The average price that SECT-B.ST shares were previous bought at was SEK 21.7917. The current market price is 13.1% higher than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 44,382 (USD $4,496) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| GETI-B.ST - | HOLD | 0 @ SEK 17.6018 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 17.6018. The average price that GETI-B.ST shares were previous bought at was SEK 18.4135. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in GETI-B.ST has fallen by SEK 13,208 (USD $1,338) compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 19.8987 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 19.8987. The average price that ALK-B.CO shares were previous bought at was DKK 19.5516. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 13,758 (USD $2,081) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 15.319 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 15.319. The average price that AMBU-B.CO shares were previous bought at was DKK 16.2983. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has fallen by DKK 34,738 (USD $5,254) compared to the previous valuation of |
| EKTA-B.ST - | HOLD | 0 @ SEK 4.35239 | SEK 0 | The current share valuation price of EKTA-B.ST based on adjusted close was SEK 4.35239. The average price that EKTA-B.ST shares were previous bought at was SEK 5.05196. The current market price is -13.8% lower than average price they were purchased at. The value of the holding in EKTA-B.ST has fallen by SEK 5,603 (USD $568) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 36.68 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 36.68. The average price that QIA.DE shares were previous bought at was EUR 42.7392. The current market price is -14.2% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 42,785 (USD $48,316) compared to the previous valuation of QIAGEN NV |
| SDZ.SW - | HOLD | 0 @ CHF 35.6179 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 35.6179. The average price that SDZ.SW shares were previous bought at was CHF 40.3859. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 84,095 (USD $102,459) compared to the previous valuation of |
| ROG.SW - | HOLD | 0 @ CHF 274.083 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 274.083. The average price that ROG.SW shares were previous bought at was CHF 288.84. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 476,618 (USD $580,696) compared to the previous valuation of |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 119.413 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 119.413. The average price that AZN.L shares were previous bought at was GBP 130.456. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 485,345 (USD $642,161) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 90.39 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 90.39. The average price that SAN.PA shares were previous bought at was EUR 101.196. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 573,813 (USD $647,988) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 15.669 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 15.669. The average price that GSK.L shares were previous bought at was GBP 16.412. The current market price is -4.5% lower than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 118,877 (USD $157,286) compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 249.8 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 249.8. The average price that EL.PA shares were previous bought at was EUR 260.835. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 172,347 (USD $194,626) compared to the previous valuation of EssilorLuxottica SA |
| LONN.SW - | HOLD | 0 @ CHF 583.504 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 583.504. The average price that LONN.SW shares were previous bought at was CHF 588.16. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 7,379 (USD $8,990) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 81.6 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 81.6. The average price that ALC.SW shares were previous bought at was CHF 82.3493. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 44,335 (USD $54,016) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 523.4 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 523.4. The average price that ARGX.BR shares were previous bought at was EUR 562.164. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 159,291 (USD $179,882) compared to the previous valuation of Argenx SE |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.4579 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.4579. The average price that HLN.L shares were previous bought at was GBP 4.61467. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 107,762 (USD $142,580) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 138.4 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 138.4. The average price that UCB.BR shares were previous bought at was EUR 165.159. The current market price is -16.2% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 201,941 (USD $228,045) compared to the previous valuation of UCB SA |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 20.955 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 20.955. The average price that BAYN.DE shares were previous bought at was EUR 20.6024. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 50,731 (USD $57,289) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 118.65 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 118.65. The average price that MRK.DE shares were previous bought at was EUR 125.212. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 15,401 (USD $17,392) compared to the previous valuation of Merck KGaA |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 21.19 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 21.19. The average price that PHIA.AS shares were previous bought at was EUR 23.8839. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 18,500 (USD $20,891) compared to the previous valuation of Koninklijke Philips NV |
| NOVN.SW - | HOLD | 0 @ CHF 97.4589 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 97.4589. The average price that NOVN.SW shares were previous bought at was CHF 98.3879. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 44,971 (USD $54,791) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 250.92 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 250.92. The average price that SOON.SW shares were previous bought at was CHF 285.779. The current market price is -12.2% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 34,462 (USD $41,987) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 44.99 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 44.99. The average price that SHL.DE shares were previous bought at was EUR 51.5254. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 19,349 (USD $21,850) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 172.942 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 172.942. The average price that GMAB.CO shares were previous bought at was DKK 172.977. The current market price is 0.0% lower than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 6,928 (USD $1,048) compared to the previous valuation of |
| STMN.SW - | HOLD | 0 @ CHF 102.889 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 102.889. The average price that STMN.SW shares were previous bought at was CHF 114.879. The current market price is -10.4% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 148,086 (USD $180,423) compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 39.5 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 39.5. The average price that FRE.DE shares were previous bought at was EUR 37.485. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 62,097 (USD $70,124) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 11.4755 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 11.4755. The average price that SN.L shares were previous bought at was GBP 11.9511. The current market price is -4.0% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 47,965 (USD $63,463) compared to the previous valuation of Smith & Nephew PLC |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 44.13 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 44.13. The average price that FME.DE shares were previous bought at was EUR 44.555. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 29,198 (USD $32,972) compared to the previous valuation of Fresenius Medical Care AG |
| ZEAL.CO - | HOLD | 0 @ DKK 56.8438 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 56.8438. The average price that ZEAL.CO shares were previous bought at was DKK 78.5672. The current market price is -27.6% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 70,484 (USD $10,661) compared to the previous valuation of |
| SOBI.ST - | HOLD | 0 @ SEK 23.5769 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 23.5769. The average price that SOBI.ST shares were previous bought at was SEK 26.0522. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 36,296 (USD $3,677) compared to the previous valuation of |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 50.54 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 50.54. The average price that ERF.PA shares were previous bought at was EUR 48.9037. The current market price is 3.3% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 9,258 (USD $10,455) compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 214 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 214. The average price that SRT3.DE shares were previous bought at was EUR 219.465. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 198,540 (USD $224,205) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.9929 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.9929. The average price that CTEC.L shares were previous bought at was GBP 2.87216. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 23,492 (USD $31,082) compared to the previous valuation of ConvaTec Group PLC |